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Abstract.  We previously demonstrated that a hetero- 
typic complex of the two rat asialoglycoprotein recep- 
tor subunits was assembled during cell-free translation 
(Sawyer,  J.  T., and D.  Doyle.  1990. Proc.  Natl. Acad. 
Sci.  USA.  87:4854--4858).  We have characterized this 
system further by analyzing polypeptide interactions 
under both reducing and oxidizing translation condi- 
tions. This report shows that the complex represents a 
heterogeneous interaction between reduced membrane 
proteins rather than a specific  oligomeric structure. In 
the reduced state membrane proteins interact in this 
system to form aggregates of diverse size and compo- 
sition. The aggregated nascent polypeptides interact 
with the immunoglobulin heavy chain binding protein 
but this protein is not an integral component of the 
aggregate.  Aggregation occurs via the exoplasmic do- 
main, rather than the transmembrane domain, and the 
folding of this domain by the formation of intramolec- 
ular disulfides, prevents the interaction from occur- 
ring. Additionally, the folded molecules containing 
intramolecular disulfides lack high affinity binding ac- 
tivity and thus appear to resemble the earliest folding 
intermediates seen in vivo (Olson, J.  T., and M. D. 
Lane.  1989. FASEB (Fed. Am.  Soc.  Exp.  Biol.) J.  3: 
1618-1624).  These results lead us to suggest that the 
formation of intramolecular disulfides during early 
biogenesis serves  to prevent nonspecific associations 
between nascent polypeptides. 
S 
TUDIES of early events along the secretory pathway in- 
dicate  that  misfolded  or  unassembled  proteins  are 
often not transported along their targeted pathways, but 
are retained instead within the ER (Rose and Doms,  1988; 
Hurtley and Helenius,  1989). In some cases  the retained 
molecules are found in association with accessory proteins 
resident in the ER lumen such as the Ig heavy chain binding 
protein (BiP) ~  (Bole et al., 1986; Hurtley et al., 1989). Re- 
tention can also result from the aggregation of  misfolded pro- 
teins  in the absence  of significant interaction  with an ac- 
cessory  factor  (Rose  and  Doms,  1988). Aggregation  is 
commonly thought to result from the exposure of cysteine 
residues or hydrophobic domains (Rose and Doms,  1988). 
Since membrane proteins are in general oligomeric, control 
of the early folding events leading to the correct assembly 
is a significant problem with respect to the organization of 
the cell surface and membrane-bound  organelles. 
We have been using the mammalian asialoglycoprotein re- 
ceptor to study this general problem. The asialoglycoprotein 
receptor is a major endocytic protein of the liver which rec- 
ognizes and internalizes galactose-terminated serum glyco- 
proteins  (Spiess,  1990). Several lines of evidence suggest 
that  this  receptor  exists  on  the  cell  surface  as  a  hetero- 
oligomer of two or more subunits, depending on the species 
1. Abbreviations  used in this paper:  BiP, immunoglobulin heavy chain bind- 
ing protein; Cx-32, cormexin-32; DPP-IV, dipeptidyl peptidase IV; GSSG, 
oxidized glutathione;  PDI,  protein disulfide isomerase;  RHL, rat hepatic 
lectin. 
(McPhaul and Berg, 1986; Sawyer et al., 1988; Bischoff et 
al., 1988; Shia and Lodish, 1989). The receptor is preferen- 
tially expressed on the basal surface of hepatocytes (Matsu- 
ura et al., 1982; Geuze et al., 1982) and a similar polariza- 
tion is evident in transfected MDCK  cells (Graeve et al., 
1990).  Therefore,  the  asialoglycoprotein  receptor  should 
serve as an important model in determining relationships be- 
tween folding, assembly and vectorial transport. 
In previous work, translation of the two subunits of the rat 
asialoglycoprotein receptor  (also known as the rat hepatic 
lectin [RHL]) in a cell-free system containing pancreatic mi- 
crosomes resulted in efficient assembly ofa heterotypic com- 
plex (Sawyer and Doyle, 1990). Assembly was thought to be 
specific to the RHL subunits (called RHL-1 and RHL-2/3) 
since a truncated form of an unrelated membrane glycopro- 
tein, dipeptidyl peptidase IV (DPP-IV), was not incorporated 
into the complex. Further characterization of  this system has 
demonstrated that the interaction of RHL subunits actually 
represents a nonspecific complex, or aggregate, of inactive 
molecules lacking disulfide bonds which is generated under 
reducing translation conditions. These polypeptides interact 
in a heterogeneous fashion through their exoplasmic domains. 
When  the  exoplasmic domain  is  truncated,  or  when  the 
molecules are synthesized under oxidizing translation condi- 
tions which allow the exoplasmic domain to begin folding, 
the subunits do not aggregate. 
These experiments show that reduced membrane proteins 
have the  intrinsic  capacity  to interact  in a heterogeneous 
fashion within microsomal vesicles. We suggest that hetero- 
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pathway in vivo and anticipate that cells have a mechanism 
controlling nonspecific nascent chain interactions. Since the 
nonaggregated, oxidized polypeptides resemble early fold- 
ing intermediates in other systems (Olson and Lane, 1989), 
we propose that the rapid folding of polypeptides during 
translocation into the lumen of the ER (Bergman and Kuehl, 
1979; Peters and Davidson, 1982; Braakman et al.,  1991) 
serves as a control mechanism preventing nonspecific, het- 
erotypic aggregation. 
Materials and Methods 
Materials 
SP6 RNA polymerase, canine pancreatic  microsomes, rabbit reticulocyte 
lysate, nucleotides, RNAsin, and all restriction enzymes except for Ball 
were obtained  from Promega Biotec (Madison,  WI);  Ball and [358]methi- 
onine (>1,000 Ci/mMol; 1Ci=37 GBq) were from Amersham Corp. (Ar- 
lington Heights, IL); cap analogue 7-methylguanosine  (5') triphospho- 
gnanosine  and protein A-Sepharose  were from Pharmacia  Fine Chemicals 
(piscataway, NJ); purified Triton X-100 (Surfact-Amps  X-100) was from 
Pierce Chemical Co. (Rockford, IL);  oxidized glutathione (GSSG) was 
from Sigma Chemical Co. (St. Louis, MO); SDS-PA_GE  calibration  stan- 
dards were from Bothesda Research Laboratories (Bethesda, MD). RHL 
and DPP-IV cDNAs were as previously described (Sawyer and Doyle, 
1990). cDNA for connexin-32 (Cx-32) was from B.  Nicholsoo (State 
University  of New York at Buffalo). 
Antibodies 
Monoclonal  anti-BiP  was  a  gift  from  D.  Bole  (Howard  Hughes  Medical  In- 
stitute,  Ann Arbor,  MI); rabbit  polyclonal  antibody  to protein  disulfide 
isomerase  (PDI)  was  a  gift  from  R. Freedman  (University  of  Kent,  Canter- 
bury,  England);  antibody  to  Cx-32  was  a  gift  from  B.  Nicholson;  antibody 
to  native  RHL and  antibody  to  gel-purified  DPP-IV were  prepared  in  the 
Doyle  laboratory  by J.  Fetell  and  W. Hong, respectively.  The RHL-I and 
RHL-2/3 carboxy-terminal  antisera have been described (Sawyer et al., 
1988). 
In Vitro Transcriptions and Translations 
Full-length  transcripts  for RILL, DPP-IV, and Cx-32 were synthesized  with 
the Promega  Biotec ribopmbe  system  as previously  described (Sawyer and 
Doyle, 1990). Truncated transcripts were made by linearizing cDNAs 
within  the coding  sequence  as indicated  in the results. Translations  were as 
previously described and included four equivalents  of pancreatic micro- 
somal membranes  as defined  by the manufacturer  (Sawyer and Doyle, 1990) 
with the exception  that in some  experiments  the reticuiocyte  lysate  was sup- 
plemented with GSSG to induce the formation  of disulfide  bonds. Levels 
of GSSG allowing  disulfide  formation  without inhibiting  translation  were 
determined  in trial experiments.  Actual  GSSG  concentrations  are indicated 
in the legends. 
lmmunoprecipitations 
Translation  reactions  typically  were diluted  in 20 vol of TBS containing  1% 
Triton X-100 and 5 rnM iodoacetamide (extraction  buffer). In the absence 
of iodoacetamide, intermolecular  disulfide  bonds  were generated  during  ex- 
traction. The reaction  mixture  was extracted on ice and the solubilized  ma- 
texial immunoprecipitated  as described  (Sawyer  and Doyle, 1990), In some 
experiments  the supematants  of immunoprecipitates  were collected  and im- 
munoprecipitated  a second  time  to determine  various  combinations  of chain 
interactions, mAbs were incubated  with protein A-Sephatose before im- 
munoprecipitations  were carded out. To assay for BiP or PDI association 
with nascent chains, translation  cocktails were depleted of ATP by treat- 
ment with apyrase (45 U/ml final concentration)  for 2 rain at 30~  before 
extraction  and immunoprecipitation.  Immunoprecipitates  were analyzed  by 
SDS-PAGE according  to Laemmli  (1970) and the labeled  proteins  detected 
by fluorography  (Bonner  and Laskey, 1974). Fluorograms  were quantitated 
by excising  the desired  bands from dried gels and counting  their radioactiv- 
ity by liquid scintillation  counting. 
Ligand Binding Assays 
Translation  reactions  were extracted with 20 vol 10 mM Tris, 1.25 M NaCI, 
50 mM CaCi, 0.5% Triton X-100, pH 7.8 (loading  buffer) (Hudgin  et al., 
1974), and the solubllized  material applied to a 1-nil  galactose-Sepharose 
column previously equilibrated with loading buffer. After 60 rain, the 
colunm was washed three times with a total of 1.5 ml loading  buffer and 
then eluted with 20 mM ammonium  acetate, 1.25 M NaC1, 0.5% Triton 
X-100  pH 5.4 (Hudgin  et al., 1974).  0.5-mi  fractions  were collected, neutral- 
ized with 1 M "Iris and immunoprecipitated  with antibody  to native  RHL. 
Sucrose Gradient Density Centrifugation 
Translation  reactions  were diluted  with  extraction  buffer  as described  above 
and applied  to a 5-mi, 5-20% continuous  sucrose gradient. Gradients  were 
spun in an SW55 Ti Rotor for 7 h at 9,700 g at 4~  0.5-ml fractions  were 
collected and immunoprecipitated  with antibody  to native RHL. 
Results 
RIlL Interactions in the Cell-free System Occur Only 
under Reducing Conditions 
Under standard translation conditions, the RHL polypep- 
tides are synthesized in their reduced forms since the com- 
mercial lysate is stabilized with 2 mM DTT (Fig. l, lanes 1, 
2, 4, 5). Supplementing the translation cocktail with GSSG 
results in the formation of intramolecular disulfide bonds as 
evidenced by an increased electrophoretic mobility under 
nonreducing conditions (Fig.  l,  lanes 3  and 6).  RHL-2/3 
shows an apparent molecular mass difference between the re- 
duced and oxidized states of ~5 kD, whereas RHL-1 shows 
a difference of '~ 3 kD. The disulfide structure of native RHL 
and the  cell-free translation products has  not been deter- 
mined. Since both subunits are identical in the number and 
position  of  cysteine  residues,  we  expect  the  pattern  of 
disulfide bonds to be conserved.  Therefore,  the  oxidized 
RHL-1 and RHL-2/3 products may represent different inter- 
mediates  in  the  folding  pathway.  Alternatively,  the  dis- 
crepancy between the RHL-1  and RHL-2/3 oxidized poly- 
Figure 1.  Synthesis  of reduced and oxidized  RHL polypeptides. 
RNAs for RttL-1 and RHL-2/3 were individually  translated in the 
presence of canine pancreatic microsomes  for 90' at 30~  Rabbit 
reticulocyte lysate was supplemented  with 3 mM GSSG where indi- 
cated, The products were immunoprccipitatcd  with antibody raised 
against native receptor.  The polypcptides  were subsequently ana- 
lyzed under reducing (R) or nonrexiucing (NR) SDS-PAGE condi- 
tions, o, reduced RHL-2/3; o, reduced RHL-1; o, oxidized RHL- 
2/3; I, oxidized RHL-1. Additional RHL translation  products have 
previously been described  and include primary translation prod- 
ucts,  intermediate glycosylation  products,  and internal initiation 
products (Sawyer and Doyle, 1990). Numbers in the margins of this 
and other figures indicate protein standard sizes in kilodaltons. 
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duced and oxidized RHL poly- 
peptides. The two RHL RNAs 
were  cotranslated  under  re- 
ducing (-GSSG) or oxidizing 
(+3 mM GSSG) conditions as 
indicated.  The products were 
immunopreeipitated  with an- 
tisera  specific to the carboxy 
terminus of  either RHL-1 (R/) 
or RHL-2/3 (R2), or with control serum (N1). The immunoprecipi- 
tates  were  analyzed  under  reducing  SDS-PAGE conditions,  o, 
glycosylated RHL-2/3; e, glycosylated RHL-1. 
peptides  may  reflect a  difference in  other  conformational 
features. 
As we have previously shown,  RHL polypeptides trans- 
lated under reducing conditions form a heterotypic complex 
as  demonstrated  by  coimmunoprecipitation  with  subunit 
specific antisera (Fig.  2, lanes 1-3).  In typical experiments 
,o40%  of each  subunit  is  coimmunoprecipitated  with  the 
heterologous antibody  (Sawyer and Doyle,  1990).  Consis- 
tent with a lack of disulfide bond formation the complex dis- 
sociated  into  monomeric  forms  under  nonreducing  SDS- 
PAGE conditions (data not shown). After translation under 
oxidizing conditions, however, the RHL polypeptides do not 
coimmunoprecipitate as a heterotypic complex (Fig. 2, lanes 
4-6). GSSG is commonly found to reduce the yield of trans- 
lation product through the inactivation of eukaryotic initia- 
tion factor 2 (Ernst et al.,  1978; Scheele and Jacoby, 1982). 
Titration of RNA over a  10-fold range indicates that the re- 
duced subunits interact at concentrations  much lower than 
obtained in the presence GSSG (data not shown), indicating 
the slight decrease in the level of translation products evident 
in the presence of GSSG (Fig. 2, lanes 4-6) is not significant 
with respect to subunit interactions. Therefore, folding of  the 
polypeptide  chains  as  indicated  by  the  formation  of  in- 
tramolecular disulfides prevents heterotypic complex forma- 
tion.  It appears that only reduced RHL molecules interact 
during cell-free translation. 
"Unfolded" RIlL Polypeptides Interact NonspecificaUy 
To determine  whether  the oxidized polypeptides represent 
legitimate intermediates  in the folding pathway we assayed 
their  functional  state  by  binding  to  galactose-Sepharose. 
Drickamer and co-workers have shown that both RHL-1 and 
RI-IL-2/3 can bind independently to galactose-Sepharose af- 
ter cell-free translation  (Hsueh et al.,  1986; Halberg et al., 
1987).  As might  be expected,  each  subunit  appears  com- 
pletely  inactive  after  translation  under  standard  reducing 
conditions. All of the product applied to the affinity column 
is released in the flowthrough and the first wash fraction (Fig. 
3, A and D).  Therefore, subunits translated under reducing 
conditions lack the native tertiary structure as indicated by 
the apparent absence of a high affinity binding site, and the 
lack of  disulfide bonds. We refer to these as "unfolded" mole- 
cules. When translated  in the presence of GSSG the mole- 
cules show low affinity binding as evidenced by retardation 
on the column (Fig.  3, B and E).  The fraction of material 
which is retarded by the column  increases after a  "chase" 
with a higher concentration of GSSG which inhibits further 
l~gure 3.  Ligand binding activity of reduced  and oxidized RHL 
molecules. RI-IL  subunits were independently synthesized under re- 
ducing or oxidizing conditions, as previously described.  In some 
cases, the reactions were brought to 5 mM GSSG and incubated 
for 2 h. The translation products were applied to a galaetose-Sepha- 
rose affinity column and the flowthrough (lane 1), colunm washes 
(lanes 2-4), and eluate fractions (lanes 5-7) were immunopreeipi- 
tated with antibody to native RHL. 
translation (Fig. 3, C and F). This is indicated by a reduced 
amount of material  in the flow-through and an increase in 
material  eluted at pH 5.4.  In the case of RHL 2/3 a  small 
peak of apparently high affinity binding is evident by quan- 
titative analysis of the elution profile (data not shown). The 
inclusion of GSSG in the initial translation reaction, there- 
fore, induces the formation of intramolecular disulfides but 
does not result in folding of a high affinity binding site. The 
"step-wise" effect of GSSG suggests that the oxidized transla- 
tion products are intermediates in the early folding pathway. 
The formation of these putative folding intermediates  is at 
the expense of the interaction between the two chains. 
In previous work we used a truncated version of DPP-IV 
to demonstrate  subunit specificity in  the RHL heterotypic 
complex  (Sawyer and  Doyle,  1990).  This  apparent  spec- 
ificity  has  been  reinvestigated  using  full-length  DPP-IV. 
Under  reducing  conditions  full-length  DPP-IV was eoim- 
munoprecipitated  with each RHL subunit (Fig.  4  a,  lanes 
1-3). Curiously, the interaction between RHL and DPP-IV 
was not detected with DPP-IV antibody (Fig. 4 a, lane 4). 
Most likely DPP-IV antibody either displaces RHL polypep- 
tides  or,  alternatively,  does  not  recognize  DPP-IV  when 
complexed with RHL. A similar interaction with RHL could 
be detected with a second unrelated protein, the gap junction 
protein Cx-32, which differs from RHL and DPP-IV not only 
in sequence,  but also in its transmembrane  topology (i.e., 
has multiple membrane spanning domains; Paul, 1986). Af- 
ter translation under reducing conditions, a small fraction of 
Cx-32 cotranslated with RHL-1 is immunoprecipitated with 
RI-IL-1 antibody (Fig. 4 b, lanes 2 and 3). Specificity of the 
RHL peptide antisera was verified when cotranslated prod- 
Yilla et al. Heterot~ic Chain Interactions in a  Cell-free  System  247 Figure  4.  Cotranslation  of 
RHL with  DPP-IV  and  with 
Cx-32.  RHL RNAs were co- 
translated  with  full-length or 
Stu  1 truncated,  DPP-IV (a), 
or with Cx-32 (b) under reduc- 
ing or oxidizing conditions as 
indicated.  The Stu  1 trunca- 
tion was to a unique site in the 
exoplasmic  domain  resulting 
in the removal of 435 aa resi- 
dues. The products were immu- 
noprecipitated  with  carboxy- 
terminal antisera to each RHL 
subunit,  antibody  to  gel-pu- 
rified DPP-IV, carboxy-termi- 
nal antisera to Cx-32 or with control serum (NI). (o) Glycosylated RHL-2/3; (o) glycosylated RHL-1; (A) full-length glycosylated DPP- 
IV; (A) Stul truncated  glycosylated DPP-IV; (v) unglycosylated RHL-1; (x) Cx-32; (~), RHL-1 internal  initiation product. 
ucts were extracted in SDS. Under these conditions, only the 
homologous RHL protein was immunoprecipitated (data not 
shown).  After  translation  under  oxidizing  conditions  the 
RHL polypeptides do not coimmunoprecipitate with DPP- 
IV or Cx-32 (Fig. 4 a,  lanes 5-7, Fig. 4 b, lanes 5  and 6). 
Therefore, reduced, but not oxidized, RHL molecules inter- 
act not only with each other but with membrane proteins that 
are unrelated both in sequence and in transmembrane topog- 
raphy.  The  initial  folding  of the  RHL polypeptide chains 
serves to prevent the heterogeneous interaction displayed by 
reduced molecules without producing a high affinity ligand 
binding site. 
The Nonspecific Chain Interactions Generate 
Aggregates of Various Sizes and Compositions 
To further characterize the interactions of the reduced poly- 
peptides, we sought to determine if distinct sizes and types 
of complexes were generated.  Not  surprisingly,  we  found 
that both RHL polypeptides were present as a heterogeneous 
population of sizes which  included  monomers and a  con- 
tinuum  of  oligomeric  forms  when  analyzed  by  velocity 
sedimentation  over sucrose  gradients  (Fig.  5,  A  and  B). 
Though no distinct oligomeric peak was evident,  "~50%  of 
the total product was found associated with high molecular 
weight  complexes (Table  I).  In  contrast,  the  oxidized 
subunits sedimented largely as monomers (Fig. 5,  C and D 
and Table I). Thus interactions between the "unfolded" RHL 
subunits generate complexes of heterogeneous size.  Oligo- 
mers are  not  in  equilibrium  with  monomers in  the  deter- 
gent extract as indicated by experiments in which pooled gra- 
dient fractions were re-run on a second gradient. Thus, the 
3.5S pool (fractions 1-4) was recovered in the 3.5S position 
when run on a  second gradient (data not shown). 
Since  sedimentation  analysis  indicated  that the  reduced 
polypeptides could interact to generate aggregates of diverse 
size we expected a  diversity of chain composition as well. 
For example,  we expected the  interaction of DPP-IV with 
RHL (Fig. 4 a) to generate complexes containing all three 
chains.  Alternatively,  DPP-IV  might  interact  with  only 
RHL-1  or  RHL-2/3  individually.  To  distinguish  between 
these alternatives, a cotranslation of DPP-IV and both of the 
RHL  subunits  was  successively  immunoprecipitated  with 
Figure 5.  Velocity sedimentation  analysis of RHL polypeptides. 
RHL subunits were translated under reducing or oxidizing condi- 
tions and the products were then subjected to continuous sucrose 
gradient density centrifugation. The gradient fractions were immu- 
noprecipitated with antibody to native receptor. The sedimentation 
of standards  run on a  separate  gradient,  is indicated  by arrows 
above (ovalbumin, 3.5S; immunoglobulin 6.5S; thyroglobulin 18S). 
Table L  Quantitative  Analysis of Sucrose Gradients 
RHL-I  RHL-2/3 
GSSG  M  O  M  O 
-  48.0  +  0.31  51.7  +  1.62  55.1  +  1.62  44.8  +  1.62 
+  81.7  +  6.64  18.3  +  6.64  82.0  +  3.11  13.0  +  3.11 
Glycosylated bands were excised from gels similar to Fig. 5 and quantitated 
by liquid scintillation counting. The incorporated radioactivity from individual 
column fractions was combined into monomeric (M) pools (fractions  I-5) or 
oligomeric (O) pools (fractions 6-12).  The numbers below represent a statisti- 
cal  average  of three  separate  gradient  runs and  indicate the  percentage  of 
product per fraction relative to total product  present. 
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First Ab:  NI  anti-RHL-I  anti-RHL-213 
Second Ab: 
RHL-I  435  +  29.7*  44  :t:  14.7  249  :t:  17.6" 
RHL-2/3  250  +  38.5*  105  +  12.7'  35  +  8.1 
The product of a cotranslation of DPP-IV, RHL-I and RHL-2/3 was extracted 
in the  presence  of Triton  X-100  and the  supernatant  assayed  with peptide- 
specific RHL antibodies (anti-RHL-1 and anti-RHL-2/3) and with nonimmune 
sera (NI).  After  removal  of immune complexes  by  adsorption  with protein 
A-Sepharose,  the supernatant was assayed with either anti-RHL-1 or with anti- 
RHL-2/3.  The glycosylated  DPPIV bands were excised from dried gels and 
radioactivity incorporated was counted by liquid scintillation counting. Experi- 
ments were done  in triplicate  and  the data  analyzed according  to Dunnen. 
* P value  =  0.0001. 
the RHL antibodies. Anti-RHL-1 coimmunoprecipitated an 
average of 435 cpm in DPP-IV from three experiments (Ta- 
ble II, column/). This decreased by "~40% to 249 cpm when 
preceded by immunoprecipitation with anti-RHL-2/3 (Table 
II,  column 3).  Similarly, RHL-1  immunoprecipitation de- 
creased the pool ofDPP-IV complexed to RHL-2/3 by ,~50% 
(Table II, columns I and 2). This demonstrates that approxi- 
naately one-half of the DPP-IV  molecules which  interact 
with RHL-1 also interact with RHL-2/3. Therefore, the com- 
plexes can contain all three polypeptides. Based on the lack 
of specific chain interactions, and the lack of a specific size 
and chain composition, it appears that the complexes formed 
under reducing conditions represent the random aggregation 
of multiple chains. 
"Unfolded" RHL-1 and DPP-IV Interact via 
Their Exoplasmic Domain 
Since DPP-IV truncated to remove 435 aa residues in the 
exoplasmic domain does not interact with "unfolded" RHL 
(Sawyer and Doyle, 1990, and Fig. 4 a, lanes 9-12), we ex- 
amined the role of the exoplasmic domain of RHL-1 in the 
interaction with RHL-2/3. cDNA to RHL-1 was linearized 
at various sites within the coding region of the exoplasmic 
domain. The resulting run-off transcripts were cotranslated 
with full-length RHL-2/3.  Removal of up to  105  residues 
Rostrietion  Prod~t  No. of aa  R2 
~  Copreeipitated 
(~__L 
I~r  N  ?M  .~]i  ,'~,I  t  ,  t  ,t C  204  (F~llLengtb.)  100 
P•ll  I  II  i  I  i  267  100 
B~  [  i  ii  i  i  I  260  100 
B$1~I  I  II  i  I  241  75 
Apllt  I  I  I  I  I  204  8B 
~Cal  I  I t  179  69 
Hh~IIl  1 ~G  13 
Figure 6. Truncated RHL-t interactions with RHL-2/3. cDNA for 
RHL-1 was linearized within the coding region as indicated. The 
RNAs were individually cotranslated with RHL-2/3 and the reac- 
tion terminated by treatment with 1 mM puromycin for 20 min 
(Adelman et al.,  1973). The products were immunoprecipitated 
with a peptide antisera made to a region 35 aa residues outside the 
transmembrane domain between residues 90 and 106. Radioactivity 
in glycosylated RHL-2/3 bands was counted. The amount of RHL- 
2/3 coimmunoprecipitated with each RHL-1 protein is expressed as 
a function of that associated with full-length RHL-1. The trans- 
membrane domain of RHL-1 is indicated as TM, N-linked gly- 
cosylation sites and cysteine residues are indicated by tall and short 
lines, respectively. 
from the carboxy-terminal domain of RHL-1 is largely with- 
out effect on coimmunoprecipitation with RHL-2/3 (Fig. 6). 
Truncation of an additional 43 residues with HindlR, how- 
ever, essentially eliminated the interaction with RHL-2/3. 
Therefore, the nonspecific interactions of both RHL-1 and 
DPP-IV can be prevented through truncation of the carboxy- 
terminal exoplasmic domains. In the case of RHL-1, interac- 
tion with other "unfolded" proteins minimally involves a 43 
amino acid stretch in the exoplasmic domain.  The trunca- 
tions which prevent aggregation remove 10 of 13, and 8 of 
8 cysteine residues in the exoplasmic domains of DPP-IV and 
RHL-1, respectively. This correlates well with the negative 
effect of the folding of the exoplasmic region via the forma- 
tion of intramolecular disulfides on aggregation. In addition, 
this  result  clearly  indicates  that  the  RHL  and  DPP-IV 
subunits are not aggregated at their hydrophobic transmem- 
brane domains in this system. 
The "Unfolded" Polypeptides do Not Interact 
through BiP or PDI 
Since RHL interactions in this system involve reduced and 
apparently unfolded polypeptide chains, it seemed likely that 
the subunits interact with BiE and that BiP might in fact be 
an integral part of the complex. The usual conditions of our 
immunoprecipitations, however, do not favor stable interac- 
tions between BiP and other proteins (Munro and Pelham, 
1986; Kassenbrock et al., 1988). This was confirmed by im- 
munoprecipitation with BiP mAb (Fig. 7, lane 4). The re- 
duced RHL polypeptides coimmunoprecipitate with BiP but 
only after depletion of ATP with apyrase (Fig. 7, lane 6). Im- 
munoprecipitation of the RHL aggregate, on the other hand, 
is not dependent on apyrase treatment (Fig. 7, lanes 1-3). In- 
terestingly, apyrase treatment reveals a nearly quantitative 
interaction between BiP and RHL implying that BiP associ- 
ates with both monomeric and aggregated RHL. We also 
looked for interaction between RHL and PDI but could not 
detect any coimmunoprecipitation of RHL with PDI anti- 
body (Fig. 7, lanes 5 and 7). Thus, the RHL interactions are 
stable under conditions which do not allow coimmunopre- 
cipitation with two major lumenal proteins, BiP and PDI. 
The RHL subunits will bind to BiE but BiP is not an integral 
component of the heterogeneous complex. 
Discussion 
Heterogeneous Interactions of  Membrane Proteins 
during Cell-free Synthesis 
Several studies have strongly suggested that the asialoglyco- 
protein receptor exists as a heterooligomeric complex of two 
or more subunits (McPhaul and Berg, 1986; Sawyer et at., 
1988; Bischoffet al., 1988; Shia and Lodish, 1989). We pre- 
viously reported that a heterooligomeric RHL complex was 
assembled during cell-free translation (Sawyer and Doyle, 
1990). A truncated form of an unrelated protein, DPP-IV, 
was used as a control for specificity in those experiments. 
When  synthesized with  the  RHL  subunits,  the  truncated 
DPP-IV was excluded from the RHL complex. In this work 
we  show  that under  identical translation  conditions,  full- 
length DPP-IV coimmunoprecipitates with RHL. Addition- 
ally, the gap junction protein Cx-32 also coimmunoprecipi- 
tates with RHL. This demonstrates that the interaction iden- 
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of RHL translation products 
with  anti-BiP and  anti-PDI. 
RHL RNAs were cotranslated 
under reducing  conditions  and 
the reaction was treated with 
apyrase where indicated  to de- 
plete ATP before extraction. 
The products were immunoprecipitated with the carboxy-terminal 
RHL antisera, mAb to BiP, polyclonal antibody to PDI, or with 
control serum (NI), o,  glycosylated RHL-2/3;  o,  glycosylated 
RHL-I. 
tiffed here is not chain specific. Furthermore, the interaction 
requires elements within the exoplasmic domain as indicated 
by carboxy-terminal truncations of  both DPP-IV and RHL-1. 
Therefore, it was the use of the truncated version of DPP-IV 
that led to the apparent specificity in the previous work. This 
truncation, which lacks 435 aa residues in the COOH termi- 
nus was used instead of the full-length DPP-IV because it is 
more readily glycosylated in the cell-free system. Further 
characterization demonstrates that these nonspecific chain 
interactions involve  "unfolded" polypeptides and generate 
aggregates of  diverse size and chain composition. Since these 
aggregates form under reducing conditions preventing disul- 
fide formation, the chains interact noncovalently. 
A number of molecular chaperones or polypeptides chain 
binding proteins are thought to bind nascent chains in the ER 
lumen and other cellular compartments (Pelham, 1989; Roth- 
man, 1989; Ellis and van der Vies,  1991). We chose to look 
for the presence of two obvious candidates, BiP and PDI in 
the nonspecific aggregate. Anti-BiP, but not anti-PDI, co- 
immunoprecipitates reduced RHL in our experiments in an 
ATP-sensitive  fashion. Since the aggregate is stable under 
conditions that dissociate BiP-aggregate interactions, BiP is 
not an integral component of  the complex. Therefore, the na- 
scent  polypeptides  do  not  interact  by  indirect  contact 
through BiP or PDI. The polypeptides most likely interact 
by direct contact, or alternatively, the nascent chains could 
be bridged through other unidentified lumenal proteins. 
It appears from our data, that aggregation involves the exo- 
plasmic surface, and not the transmembrane domain. This 
conclusion stems from the observation that carboxy-terminal 
truncated DPP-IV or RHL-1, two type II membrane proteins, 
do not aggregate. A series of truncations in the exoplasmic 
region of RHL-I revealed that removal of a segment of 43 aa 
residues between the HindlII and ScaI sites prevented the in- 
teraction from occurring. It is unlikely that this domain con- 
tains a  determining recognition sequence for aggregation, 
since the interaction occurs between diverse polypeptide 
chains. In all likelihood, this region contains simple struc- 
tural determinants conducive to aggregation that represent a 
minimal requirement for interaction. 
Small  regions of hydrophobicity as  modeled by Chou- 
Fasman predictions, extend through the COOH-terminus of 
RHL. DPP-IV contains a large hydrophobic segment in the 
COOH-terminal region that does not appear to be embedded 
in the membrane (Hong and Doyle,  1988).  These hydro- 
phobic regions could serve as the locales for aggregation. 
Alternatively, a second mode of interaction is suggested by 
the placement of cysteine residues with respect to the car- 
boxy-terminal truncations that prevent aggregation. These 
truncations each remove the bulk of the exoplasmic cysteine 
residues, 10 of 13 in DPP-IV and all 8 in RHL-1. Addition- 
ally, Cx-32 has three cysteine residues in each of its two exo- 
plasmic loops. It is possible that these cysteine residues inter- 
act via hydrogen bonding. Disulfide formation could prevent 
aggregation by burying hydrophobic regions or alternatively, 
by preventing sulfhydryl-mediated  hydrogen bonding. In sug- 
gesting a model of early folding versus aggregation, Cx-32 
presents a dilemma because it contains numerous transmem- 
brane domains with limited exoplasmic sequence. Whether 
the exoplasmic domain of Cx-32  "folds" or how it would 
otherwise regulate aggregation sites remains intriguing. 
Relevance of the Cell-free System 
It has been suggested that oligomerization of  membrane pro- 
teins fails to occur during cell-free translation because of a 
lack of multiple insertions into microsomal vesicles (Ander- 
son and Blobel, 1981; Kvist et al.,  1982).  The nonspecific 
aggregates  described  here  contain  multiple polypeptides, 
implying that many insertions into microsomal membranes 
do occur in these experiments. This suggests that the failure 
of the oxidized RHL polypeptides to oligomerize must be 
due  to  some other  factor.  Studies in other  systems have 
shown  that  oligomerization of membrane  proteins  com- 
monly occurs in the ER (Hurtley and Helenius, 1989).  Evi- 
dence that the asialoglycoprotein receptor also oligomerizes 
in the ER is provided in studies which demonstrate that one 
subunit can be rescued from rapid degradation in the ER 
when coexpressed  with the second subunit in transfected 
cells (Shia and Lodish, 1989; Graeve et al.,  1990).  Hence 
we assume that microsomal vesicles should promote RIlL 
oligomerization during cell-free translation. Since the oxi- 
dized RHL polypeptides lack high affinity ligand binding 
activity, later folding events may not be occurring in the 
microsomes. As has been suggested in other systems, oligo- 
merization might be a late event occurring between com- 
pletely folded subunits (Gething et al.,  1986;  Copeland et 
al.,  1988; Doms et al.,  1988).  Therefore, we suggest that a 
lack of  complete folding in this system causes failure of RHL 
to oligomerize. Alternatively, there may be specific cellular 
factors necessary for oligomerization lacking in this system. 
Analysis of early events in assembly indicate that mem- 
brane  and  secretory proteins  begin to  fold and form in- 
tramolecular disulfides immediately upon insertion into the 
ER lumen (Bergman and Kuehl, 1979; Peters and Davidson, 
1982;  Braakman et al.,  1991). This rapid, even cotransla- 
tional, formation of intrachain disulfides results in receptor 
molecules lacking ligand binding activity. Activity is then ac- 
quired over a period of time in the ER (Olson and Lane, 
1987; Olson et al.,  1988).  This lag between early disulfide 
bond formation and acquisition of ligand binding is thought 
to  involve  rearrangement  of  mispaired  disulfide  bonds 
formed during, or immediately after, translation (Olson and 
Lane, 1989).  The rearrangement of disulfides appears to be 
part of the mechanism determining differential rates of ex- 
port from the ER (Lodish and Kong, 1991). 
Translation in vitro in the presence of GSSG mimics the 
early folding stages in vivo by producing molecules which 
have acquired intramolecular disulfides but not yet attained 
high affinity binding capability. When RHL is synthesized in 
the presence of low concentrations of GSSG, there is an ob- 
servable effect on its ability to bind to a galactose-Sepharose 
column.  The  apparent  binding  affinity increases  with  a 
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due to new synthesis since translation is inhibited at the 
higher concentration of GSSG (data not shown). The %tep- 
wise" effect of OSSG in increasing the apparent affinity of 
ligand binding leads us to propose that the oxidized mole- 
cules represent intermediates in the folding pathway of  RHL. 
Presumably,  the  effect of longer  incubations with GSSG 
would be to allow correct, stably folded structures to form 
via disulfide rearrangement. Hille et al.  (1989)  reported a 
similar increase in ligand binding ability of the 46-kD man- 
nose 6-phosphate receptor, dependent on the concentration 
of GSSG during cell-free translation, which was associated 
with conformational changes. Hence we believe the oxidized 
RHL polypeptides are receptor molecules in the early stages 
of folding. 
Nascent polypeptide chains are presumably maintained in 
an unfolded state during translocation across the ER mem- 
brane as for other cellular membranes (Eilers and Schatz, 
1986; Randall and Hardy, 1986). The consequence of the in 
vitro reducing condition appears to be to passively maintain 
nascent chains in this unfolded state. Therefore, the initial 
folding events which occur rapidly in vivo can be regulated 
through manipulation of the redox conditions in the cell-free 
system. Providing a reducing environment in vitro has re- 
vealed an unproductive assembly pathway for nascent chains. 
Regulation of Chain Interactions during Biogenesis 
It has been suggested that aggregation occurs as an alterna- 
tive to entry into a proper folding pathway (Jaenicke, 1987). 
Inactive aggregates of soluble proteins are a common occur- 
rence in in vitro folding experiments with purified enzymes 
(King, 1989; Gatenby and Ellis, 1990).  Membrane proteins 
have also been shown to aggregate in vivo, in the absence of 
proper folding processes.  For example, newly synthesized 
chains of the temperature-sensitive vesicular stomatitis virus 
G protein mutant, ts045, aggregate noncovalently at the non- 
permissive temperature and display aberrant folding (Doms 
et al., 1987; deSilva et al., 1990). These aggregates of mem- 
brane and soluble proteins have generally represented homo- 
typic interactions. In contrast, the aggregates described in 
this report include heterotypic chain interactions. Addition- 
ally, the experiments described here lack the overt denatura- 
tion common to in vitro refolding experiments. Rather, the 
reducing environment of the cell-free system passively cap- 
tures nascent chains in an "unfolded" state as they are ex- 
posed in the microsomal lumen which results in heterotypic 
aggregation of the exoplasmic domains. Do nascent chains 
aggregate in vivo as an intermediate during early biogenesis? 
We are not aware of any experimental data to support this 
model. It is more likely that heterotypic aggregation repre- 
sents an alternative, dead-end pathway which deviates from 
the normal pathway essentially upon exposure of the nascent 
chains in the ER/microsomal lumen. Thus, our experiments 
infer a mechanism operating in vivo on nascent chains to 
suppress  the unproductive pathway.  Once segregated,  na- 
scent chains can develop characteristic folds which are the 
basis for specific chain interactions. 
Much current interest has focused on a role for accessory 
factors or molecular chaperones for such a function (Gatenby 
and Ellis,  1990).  The data presented here suggest that any 
such factors present in pancreatic microsomes are not suf- 
ficient to segregate reduced chains. In fact one of these fac- 
tors, BiP, apparently binds the aggregated forms. Thus, inter- 
action with BiP does not prevent reduced RHL chains from 
aggregating. Alternatively, the immediate oxidizing environ- 
ment permitting folding may be a necessary condition in pre- 
venting nonspecifiC interactions. Since it has been demon- 
strated that the absence of accessory factors can result in a 
lack of folding even when the redox environment is condu- 
cive (Bullied and Freedman, 1988),  both accessory factors 
and an oxidizing environment may be necessary for inhibit- 
ing heterotypic aggregation without either being sufficient. 
In our system it could be argued that BiP recognizes the ag- 
gregated polypeptides as aberrant, binds in an effort to cor- 
rect the aberration, but is unable to do so due to the reducing 
environment of the in vitro microsomal lumen. Therefore, 
we propose that it is not chaperone binding per se which con- 
trols aggregation, but the rapid folding of the polypeptide 
upon exposure to the lumen of the ER. 
We propose a working model whereby conditions favoring 
the rapid formation of intramolecular disulfides have been 
selected to counteract an intrinsic capacity of membrane 
proteins to aggregate with one another. In this model the ear- 
liest folding events are interpreted as a control mechanism 
which "chooses" a pathway resulting in properly folded and 
oligomerized proteins for export from the ER. We believe 
our model explains the otherwise curious feature of the ap- 
parent "mispairing" of cysteines which occurs in some mem- 
brane and secretory proteins during biogenesis as a result of 
cotranslational disulfide formation. These mispaired disul- 
fides, which have to be reshuffled to achieve the active con- 
formation, are tolerated because their formation prevents the 
presumably dead-end pathway of heterotypic aggregation. 
The model predicts that if disulfide formation in the ER is 
inhibited, nascent membrane, and perhaps secretory, pro- 
teins would interact with unrelated proteins to form nonspe- 
cific aggregates. 
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